CLINICAL_TRIALS
trial_result
· 2022-08-09
Clinical Trial Update: A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) [Phase 2]
Summary
Phase 2 study of mavacamten in adults with symptomatic non-obstructive hypertrophic cardiomyopathy has completed with results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: MyoKardia, Inc. | Conditions: Non-obstructive Hypertrophic Cardiomyopathy | Phase 2 | Status: COMPLETED | Results posted: 2022-08-09